RORA and systemic lupus erythematosus: These findings indicate that Gala-SR is effective systemically, that may also of great promise for the therapy of systemic inflammatory diseases related to RORα abnormalities, such as primary Sjogren’s syndrome,49 diabetes,50 and systemic lupus erythematosus.51